(Press-News.org) (TORONTO, Canada – Dec. 29, 2011) – Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs. Amit Oza of the Princess Margaret Cancer Program, University Health Network and Timothy Perren, St James's Institute of Oncology, Leeds, UK.
The findings, published today in the New England Journal of Medicine, report that the drug halted the cancer's return for two months overall. However, for women with the highest risk disease, the delay was five to six months and in this group, the findings also indicate a strong trend to improved overall survival, which is being analysed until 2013.
"This is the first new drug in ovarian cancer in 15 years to improve outcome and I believe it should be considered as a potential new standard of care," says Dr. Oza, a medical oncologist who leads the Cancer Clinical Research Unit at Princess Margaret Hospital. He is also co-director of the hospital's Bras Family Drug Development Program and Professor, Faculty of Medicine, University of Toronto.
The seven-year study began in 2004 and enrolled 1,528 women with ovarian cancer at 263 centres, including 20 in Canada. Avastin was added to chemotherapy treatment and given intravenously every three weeks for 12 months.
The drug blocks growth factors that promote new blood vessels formation in tumours, thereby "starving" the cancer. It is not a cure, explains Dr. Oza, but has a proven track record in delaying disease progression in other types of cancer including colorectal, lung, breast, kidney and brain.
"We now know that using Avastin in ovarian cancer for even this short time improves outcomes," says Dr. Oza. "The next step is to determine if giving it for a longer period would be of even greater benefit."
Similar findings from a U.S. study are also reported in this issue of the journal. Dr. Oza says the major difference between the two studies is that the women in the American study were given twice as much Avastin. "So the question now is would half the dose for double the duration improve outcomes even more? This is an area to investigate further."
###
The Canadian Cancer Society estimates 2,600 new cases of ovarian cancer will be diagnosed this year and 1,750 women will die of the disease.
The research was funded and led by the Medical Research Council UK, with women from 11 countries participating in the study. The study was conducted in Canada by the NCIC Clinical Trials Group (NCIC CTG) at Queen's University in Kingston, Ontario in collaboration with the Medical Research Council UK. Dr. Oza's research is also supported by The Princess Margaret Hospital Foundation.
Princess Margaret Hospital and Ontario Cancer Institute, the hospital's research arm, have achieved an international reputation as global leaders in the fight against cancer. Princess Margaret Hospital is a member of the University Health Network, which also includes Toronto General Hospital, Toronto Western Hospital and Toronto Rehabilitation Institute. All are research hospitals affiliated with the University of Toronto. For more information, go to www.uhn.ca
Ovarian cancer study proves drug delays disease progression, may improve survival
2011-12-29
ELSE PRESS RELEASES FROM THIS DATE:
Targeted therapy extends progression-free survival of patients with advanced ovarian cancer
2011-12-29
PHILADELPHIA, PA (December 28, 2011)—Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer. Patients with newly diagnosed advanced ovarian cancer now typically undergo surgery and chemotherapy, but the new research suggests an additional avenue of treatment. The ...
An inside look at face transplantation
2011-12-29
Boston, MA - In March 2011, a surgical team at Brigham and Women's Hospital (BWH) performed the first full face transplantation (FFT) in the United States and went on to complete a total of three FFTs this year. Now, in the first research publication to evaluate FFT in the US, and largest series worldwide, the researchers describe details of patient preparation, novel design and execution of the operation as well as unique immunosuppression protocol allowing for lowest long-term maintenance drug regimen. They also share details of the early functional outcomes and demonstrate ...
Potentially Disastrous Consequences for Student Loan Default
2011-12-29
With high unemployment and declining household incomes, meeting student loan obligations can be difficult, if not impossible. However, defaulting on federal student loans can have disastrous consequences. The government can garnish wages, withhold tax returns, and place liens on personal property. A default can also affect a person's professional license status. It's important for student loan borrowers to note that a default should be avoided at all costs.
Missing one student loan payment makes a borrower delinquent. Nine months of delinquency puts a borrower in default. ...
Netherlands mass gathering study finds substance abuse a small but significant problem
2011-12-29
In a study of 3.8 million attendees to 249 raves over 12 years, researchers found that almost 27,897 people visited a first aid station, and more than a third (10,100) reported a substance-related problem. Of these, 515 required professional medical care, and 16 cases were life-threatening. Most (66.7%) substance-related problems were associated with ecstasy, alcohol, or both. People using GHB most often required professional medical care, although the authors found no evidence for life-threatening, acute effects of the drug. The study was conducted based on data from ...
Wrong-Way Auto Accidents in Arizona
2011-12-29
Wrong-way auto accidents are exceedingly rare, but when they occur, they often have tragic results. According to the National Highway Traffic Safety Administration (NHTSA), 23 people in Arizona died in car crashes in 2009 (the latest year with available data) when a driver entered a road against traffic or drove on the wrong side of the road.
In addition, in September 2011, two women in a sedan were killed by a man in a pickup truck travelling the wrong way on I-10 in Phoenix. Also, a wrong-way accident shut down the same freeway before Thanksgiving for several hours.
Impaired ...
Microbial communities on skin affect humans' attractiveness to mosquitoes
2011-12-29
The microbes on your skin determine how attractive you are to mosquitoes, which may have important implications for malaria transmission and prevention, according to a study published Dec. 28 in the online journal PLoS ONE.
Without bacteria, human sweat is odorless to the human nose, so the microbial communities on the skin play a key role in producing each individual's specific body odor. The researchers, led by Niels Verhulst of Wageningen University in the Netherlands, conducted their experiments with the Anopheles gambiae sensu stricto mosquito, which plays an important ...
New clues as to why some older people may be losing their memory
2011-12-29
ST. PAUL, Minn. – New research links 'silent strokes,' or small spots of dead brain cells, found in about one out of four older adults to memory loss in the elderly. The study is published in the January 3, 2012, print issue of Neurology®, the medical journal of the American Academy of Neurology.
"The new aspect of this study of memory loss in the elderly is that it examines silent strokes and hippocampal shrinkage simultaneously," said study author Adam M. Brickman, PhD, of the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University ...
Scientists fixate on Ric-8 to understand trafficking of popular drug receptor targets
2011-12-29
Half the drugs used today target a single class of proteins – and now scientists have identified an important molecular player critical to the proper workings of those proteins critical to our health.
A protein known as Ric-8 plays a vital role, according to new results from a team led by Gregory Tall, Ph.D., assistant professor of Pharmacology and Physiology at the University of Rochester Medical Center. The work was published recently in Science Signaling.
What you see, what you smell, how you feel – molecules known as G-protein coupled receptors and their prime targets, ...
Diet, nutrient levels linked to cognitive ability, brain shrinkage
2011-12-29
CORVALLIS, Ore. – New research has found that elderly people with higher levels of several vitamins and omega 3 fatty acids in their blood had better performance on mental acuity tests and less of the brain shrinkage typical of Alzheimer's disease – while "junk food" diets produced just the opposite result.
The study was among the first of its type to specifically measure a wide range of blood nutrient levels instead of basing findings on less precise data such as food questionnaires, and found positive effects of high levels of vitamins B, C, D, E and the healthy oils ...
UT Southwestern research suggests new way to ensure effectiveness of TB treatment
2011-12-29
DALLAS – Dec. 22, 2011 – A UT Southwestern Medical Center study using a sophisticated "glass mouse" research model has found that multidrug-resistant tuberculosis (TB) is more likely caused in patients by speedy drug metabolism rather than inconsistent doses, as is widely believed.
If the study published in The Journal of Infectious Diseases is borne out in future investigations, it may lead to better ways to treat one of the world's major infectious diseases. Health workers worldwide currently are required to witness each administration of the combination of drugs during ...